Abstract:Corticosteroid actions in the brain are exerted via the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR). These receptors share several structural and functional similarities but their activation in the brain triggers distinct biological actions, for instance on neuronal survival or the regulation of the hypothalamo-pituitary-adrenal axis. Like other hormone-activated receptors, the transcriptional properties of the MR and GR depend on their ability to recruit a variety of co-regulators, which modulate their activity on target promoters, in a specific manner. The N-terminal regions of the MR and GR share the smallest degree of sequence conservation, whereas they display opposite effects on the transactivation properties of these receptors; thus, they may provide surfaces suitable for receptorspecific interactions with co-regulatory proteins. Here, we employed a yeast two-hybrid system to identify molecules interacting with the N-terminal part of the MR (amino acids 170-433). This approach resulted in the isolation of representative cDNAs from all members of the protein inhibitor of activated STAT (PIAS) family of proteins as potential MR-interacting partners. In neural cells, PIAS3 exhibited a strong and specific interaction with MR, but not GR, as indicated by mammalian two-hybrid assays and co-immunoprecipitation experiments in vivo. The interaction with MR was enhanced in the presence of aldosterone, an MR agonist, and was found to occur through a conserved, serine- and acidic amino acid residue-rich domain of PIAS3. To compare the modulatory properties of PIAS proteins on MR and GR transcriptional activity in a neural environment, MMTV reporter gene assays were performed in the human neuroblastoma cell line SK-N-MC. This analysis revealed that PIAS3 can inhibit MR, but not GR, transactivation in response to their corresponding ligands. Further, it showed that PIAS1 and PIASxbeta, but not PIASy, could also inhibit MR-mediated transcription despite the lack of detected physical interaction with MR. Interestingly, PIASxbeta and PIASy dose-dependently co-activated GR, whereas PIAS1 impaired GR-induced transcription. Taken together the results reveal differential modulatory roles of the PIAS proteins on the transcriptional properties of MR and GR, thus providing new insights into the bifurcating actions of these two receptors in neural cells where they are frequently co-localized.

PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1

PIAS1 Negatively Modulates Virus Triggered Type I IFN Signaling by Blocking the DNA Binding Activity of IRF3

PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis.

PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity

PIAS3 Induction of PRB Sumoylation Represses PRB Transactivation by Destabilizing Its Retention in the Nucleus

Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap

Protein Inhibitor of Activated Stat Y (piasy) and A Splice Variant Lacking Exon 6 Enhance Sumoylation but Are Not Essential for Embryogenesis and Adult Life

Negative Regulation of NF- B Signaling by PIAS1

A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors

Control Of Specificity And Magnitude Of Nf-Kappa B And Stat1-Mediated Gene Activation Through Piasy And Pias1 Cooperation

PIAS family in cancer: from basic mechanisms to clinical applications

Regulation of Smad4 Sumoylation and Transforming Growth Factor-β Signaling by Protein Inhibitor of Activated STAT1

Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.

SUMO3 Modification by PIAS1 Modulates Androgen Receptor Cellular Distribution and Stability

IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation

Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility

USP3 Inhibits Type I Interferon Signaling by Deubiquitinating RIG-I-like Receptors

Post-translational modification of Interferon Regulatory Factor 1 (IRF1)

IRF3-binding lncRNA-ISIR strengthens interferon production in viral infection and autoinflammation

The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells

MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling